SREBF1 and fatty liver disease: Gain- and loss-of-function studies in mice have demonstrated that Nrg4 acts on hepatocytes to alleviate diet-induced hepatic steatosis by suppressing de novo lipogenesis through inhibiting LXR/SREBP1c signaling (Wang et al., 2014a).